Cytori CEO Calhoun on Stem Cell Therapies, Contract

Sept. 28 (Bloomberg) -- Christopher Calhoun, chief executive officer of Cytori Therapeutics Inc., talks about the company's $4.7 million contract with the U.S. government to develop a stem cell therapy to treat burns caused by thermal or radioactive bombs. The contract may be worth $106 million over five years if certain milestones are met. Calhoun speaks with Erik Schatzker and Sara Eisen on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Gold Bulls, Oil Bears: Keeping Up With Commodities
51:17 - James Steel, chief commodities analyst at HSBC Securities, and Bloomberg Intelligence's Peter Pulikkan examine the bull case for gold and the IEA's call boosting estimates for surplus oil. They speak on "Bloomberg Markets." (Source: Bloomberg)
  • Changing the Narrative on ‘Brexit’
  • Ray Dalio's Honest 'Radical Transparency' Approach
  • Deutsche Bank's Checklist to Regain Investor Trust